NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

As I pointed out a couple of posts ago, automation of DCVax-L production is ongoing, and will be ongoing for some time. That is a certainty.

Tooling charges can be incredibly high. That is a certainty.

iwasadiver has suggested that such charges might account for the spending to Cognate that appears far beyond what production costs should be. I agreed that it is possible. Hard to be sure, but it is a reasonable explanation.

(Not sure why we should be in a position to have to guess such things... but given that we are, it seems a good guess.)

All that communication happened in the last hour. Guess you had to be there.